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Abstract A 63-year-old man with esophageal achalasia
for more than 20 years complained of respiratory distress.
He was admitted as an emergency to the referral hospital
three months previously. Computed tomography revealed
tracheobronchial stenosis due to advanced esophageal
cancer with tracheal invasion. He underwent tracheobron-
chial stenting and chemoradiotherapy. A large tracheoe-
sophageal fistula (TEF) developed after irradiation (18 Gy)
and chemotherapy, and he was unable to eat. Thereafter, he
was referred to our hospital, where we performed esopha-
geal bypass surgery using a gastric conduit. A percutaneous
cardiopulmonary support system was prepared due to the
risk of airway obstruction during anesthesia. A small-
diameter tracheal tube inserted into the stent achieved
ordinary respiratory management. No anesthesia-related
problems were encountered. Oral intake commenced on
postoperative day 9. He was discharged on postoperative
day 23 and was able to take in sustenance orally right up to
the last moment of his life. Esophageal bypass under
general anesthesia can be performed in patients with large
TEF with sufficient preparation for anesthetic management.
Keywords Tracheoesophageal fistula  Esophageal
bypass  Tracheobronchial stent
Introduction
Tracheoesophageal fistula (TEF) is a devastating and life-
threatening complication of esophageal and bronchogenic
carcinomas. It develops in approximately 5–15 % of
patients with esophageal malignancies and in less than 1 %
of those with bronchogenic carcinoma [1, 2]. Surgical
treatment of malignant tumors is usually difficult in this
situation, and tracheobronchial or esophageal stenting is
frequently indicated to prevent respiratory failure [3].
Esophageal bypass surgery for patients with esophageal
cancer is a useful technique to palliate several symptoms,
including dysphagia and aspiration pneumonia due to TEF.
However, this option may be avoided in cases with large
TEFs because of difficulties in respiratory management
during general anesthesia. We report a case of esophageal
cancer with a large TEF that was successfully treated with
surgical esophageal bypass under general anesthesia.
Case report
A 63-year-old man who had suffered from esophageal
achalasia for more than 20 years complained of acute
respiratory distress due to stenosis of the trachea resulting
from advanced esophageal cancer with tracheal invasion.
He was admitted as an emergency to the referral hospital
and computed tomography revealed a huge esophageal
tumor significantly compressing the trachea (Fig. 1). The
patient underwent placement of a Dumon Y-shaped
tracheobronchial stent (T M Y stent:ucon) to avoid suf-
focation. He was diagnosed as having esophageal cancer
with tracheal invasion, and then underwent chemoradiation
therapy (CRT). Following 18 Gy of irradiation and a
course of chemotherapy using docetaxel, cisplatin, and
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5-fluorouracil, a large TEF developed despite significant
tumor shrinkage (Fig. 2a, b). The physician decided to
cease the CRT and treat him with the best supportive care.
Oral intake was prevented due to aspiration through the
TEF, and a gastrostomy was performed under endoscopy.
The patient was referred to our hospital as he was unable
to eat. At the time of admission, he had a good performance
status and no comorbidities. We initially considered the
possibility of esophageal stenting to close the TEF. How-
ever, as CRT significantly decreased the size of the
esophageal tumor, and there had been an esophageal dila-
tation due to pre-existing achalasia, an esophageal stent
seemed unlikely to be able to close the TEF. Therefore, we
decided to perform an esophageal bypass using a gastric
conduit after obtaining informed consent.
We prepared a percutaneous cardiopulmonary support
(PCPS) system that could be used whenever needed, and
both arterial and venous catheter sheaths were inserted
from the femoral vessels prior to an endotracheal intuba-
tion. We then intubated a 6.0 mm spiral tube under the
guidance of both bronchoscopy and X-ray guidance. A cuff
of the tracheal tube effectively sealed the space between
the stent and tracheal tube and enabled positive pressure
ventilation. We were then able to perform esophageal
bypass without using PCPS. Esophageal bypass surgery
was performed through upper abdominal and collar neck
incisions. Bypass was made using a gastric conduit through
the subcutaneous route, and esophagogastrostomy was
performed using a circular stapler. A decompression tube
was inserted into the esophagus through the distal stump
covered with the greater omentum. After the surgery was
completed, the tracheal tube was safely removed under
bronchoscopy. The patient was able to start oral intake on
postoperative day 9, and was discharged on postoperative
day 23. Though he died of respiratory failure three months
after the operation, he was able to take in sustenance orally
and to live at home after the operation.
Discussion
The prognosis for patients with a malignant TEF due to
esophageal cancer is reported to be extremely poor [4]. In
patients with TEF, oral intake is limited by paroxysmal
coughing, which results in malnutrition. In addition,
recurrent pulmonary infections and sepsis may become
direct causes of death. Therefore, closure of the TEF is
much more important than treating the underlying malig-
nancy. However, in this case, the TEF was too large to
close and the patient was treated with the best supportive
care. The most effective treatments for malignant TEF are
esophageal stenting and esophageal bypass surgery. The
Fig. 1 Chest computed tomography (CT) shows a huge esophageal
tumor significantly compressing the trachea with the stent
Fig. 2 Preoperative chest computed tomography (CT) shows a tracheoesophageal fistula. There is a space around the stent because of
chemoradiotherapy (a) and a tracheoesophageal fistula at the upper thoracic esophagus (b). The arrow shows a tracheoesophageal fistula
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covered expandable metallic stent is emerging as a superior
alternative to unexpandable esophageal prostheses. A Du-
mon Y-shaped tracheobronchial stent had already been
inserted. Although this stent succeeded in keeping the
airway open, it was ineffective at closing the TEF.
Esophageal stenting is normally considered to be one of the
treatment choices, but it seemed to be ineffective in this
case because of the enlarged esophageal caliber due to pre-
existing achalasia. Indication for bypass surgery differs
among patients. In this case, curative resection of the
esophageal tumor was impossible. There was no other way
to enable oral intake than esophageal bypass surgery,
although the patient strongly wished to eat. In addition, his
general condition was sufficient for surgery and his esti-
mated life expectancy was more than three months.
There are several reports concerning the usefulness of
esophageal bypass for malignant TEFs [5, 6]. However,
cases with a large TEF must be rare, because there is no
description of anesthetic management in these articles.
Meunier et al. [5] reported that in their series, one patient
with a large TEF died just after surgery due to airway
obstruction. The main issue in our particular case was
whether we could perform general anesthesia safely.
Firstly, an endotracheal intubation might cause migration
of the stent, resulting in suffocation. Second, positive
pressure ventilation might become insufficient during the
operation. Third, migration of the stent might also occur
when the tracheal tube is removed. We discussed all of
these problems with anesthetists and cardiovascular sur-
geons, and concluded that we should prepare the PCPS so
that it could be used whenever needed. Fortunately,
ordinary respiratory management was achieved by several
devices. We used a small-diameter tracheal tube which was
inserted into the tracheobronchial stent. The cuff of the
tube successfully sealed the space between the tracheal
tube and the stent. In order to avoid stent migration, we
used bronchoscopy and X-ray imaging for guidance during
both intubation and extubation.
In conclusion, an esophageal bypass can be performed
under general anesthesia even in patients with a large TEF,
although sufficient preparation for anesthetic management,
including the preparation of the PCPS, is needed.
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